Target type: biologicalprocess
Any process that modulates synaptic transmission by regulating a catabolic process occurring at a postsynapse. [GOC:dos]
The regulation of protein catabolic processes at the postsynapse is a complex and multifaceted process that plays a crucial role in modulating synaptic transmission. This intricate interplay involves a variety of molecular mechanisms that control the breakdown and removal of proteins from the postsynaptic density (PSD), a specialized region of the postsynaptic membrane enriched with receptors, signaling molecules, and scaffolding proteins. The degradation of these proteins is essential for maintaining synaptic plasticity, a fundamental property of the nervous system that enables neurons to adapt and learn.
At the postsynapse, protein catabolism is primarily mediated by the ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway. The UPS is a highly regulated system that targets proteins for degradation by attaching a polyubiquitin chain to them. This ubiquitination signal marks the proteins for recognition by the 26S proteasome, a large protein complex that breaks down the tagged proteins into small peptides.
The autophagy-lysosome pathway, on the other hand, is responsible for the degradation of large protein aggregates and organelles. This process involves the engulfment of these structures within double-membrane vesicles known as autophagosomes. Autophagosomes then fuse with lysosomes, organelles containing hydrolytic enzymes that break down the encapsulated cargo.
The regulation of protein catabolic processes at the postsynapse is tightly controlled by a variety of factors, including neuronal activity, neurotrophic factors, and intracellular signaling pathways. For instance, increased neuronal activity triggers the upregulation of both the UPS and the autophagy-lysosome pathway, leading to the degradation of synaptic proteins and a reduction in synaptic strength. Conversely, neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), promote the stabilization and survival of synapses by inhibiting protein degradation.
Furthermore, intracellular signaling pathways, such as the mitogen-activated protein kinase (MAPK) pathway, can influence protein catabolism at the postsynapse. Activation of the MAPK pathway can promote the degradation of specific synaptic proteins, while inhibition of this pathway can have the opposite effect.
The regulation of protein catabolism at the postsynapse is essential for modulating synaptic transmission in several ways:
* **Synaptic plasticity:** Degradation of postsynaptic proteins allows for the removal of unnecessary or damaged components, enabling the synapse to adapt to changing conditions and maintain plasticity.
* **Synaptic strength:** The degradation of proteins involved in synaptic signaling, such as receptors and scaffolding proteins, can reduce synaptic strength.
* **Synaptic development:** During development, protein catabolism plays a critical role in shaping the synapse by removing excess proteins and promoting the formation of mature connections.
Dysregulation of protein catabolism at the postsynapse has been implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. In these conditions, impaired protein degradation contributes to the accumulation of misfolded proteins and the formation of toxic aggregates, ultimately leading to neuronal dysfunction and cell death.
In conclusion, the regulation of protein catabolic processes at the postsynapse is a critical aspect of synaptic function and plasticity. This intricate process involves a delicate balance between protein degradation and synthesis, ensuring the proper maintenance of synaptic connections and the modulation of neuronal communication.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ubiquitin carboxyl-terminal hydrolase 8 | A ubiquitin carboxyl-terminal hydrolase 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P40818] | Homo sapiens (human) |
Cadherin-1 | A cadherin-1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P12830] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
salvin | salvin: a biocyclic diterpenoid; from sage and rosemary (Lamiaceae) | abietane diterpenoid; carbotricyclic compound; catechols; monocarboxylic acid | angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; food preservative; HIV protease inhibitor; plant metabolite |
toxoflavin | toxoflavin : A pyrimidotriazine that is 1,6-dimethyl-1,5,6,7-tetrahydropyrimido[5,4-e][1,2,4]triazine with oxo groups at positions 5 and 7. toxoflavin: azapteridine antibiotic; structure | carbonyl compound; pyrimidotriazine | antibacterial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; toxin; virulence factor; Wnt signalling inhibitor |
cercosporin | cercosporin : An organic heterohexacyclic compound that is perylo[1,12-def][1,3]dioxepine-6,11-dione substituted by hydroxy groups at positions 5 and 12, by methoxy groups at positions 7 and 10, and by 2-hydroxypropyl groups at positions 8 and 9 (the R,R-stereoisomer). It is a phytotoxin which was first isolated from the pathogenic soybean fungus, Cercospora kikuchii and later found in multiple members of the genus Cercospora. cercosporin: phyytotoxin from Cercospora beticola Sacc; posses photodynamic action on mice, bacteria & plants | ||
ucn 1028 c | calphostin C: structure given in first source; isolated from Cladosporium cladosporioides | ||
hbx 41108 | HBX 41,108: inhibits USP7 ubiquitin protease; structure in first source |